Compare BTMD & LFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BTMD | LFT |
|---|---|---|
| Founded | 2012 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.6M | 83.3M |
| IPO Year | N/A | N/A |
| Metric | BTMD | LFT |
|---|---|---|
| Price | $2.61 | $1.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 132.4K | ★ 225.7K |
| Earning Date | 11-05-2025 | 11-12-2025 |
| Dividend Yield | N/A | ★ 10.53% |
| EPS Growth | ★ 270.48 | N/A |
| EPS | ★ 0.78 | 0.09 |
| Revenue | ★ $195,645,000.00 | $21,708,246.00 |
| Revenue This Year | N/A | $124.75 |
| Revenue Next Year | $2.80 | N/A |
| P/E Ratio | ★ $3.47 | $16.15 |
| Revenue Growth | ★ 1.34 | N/A |
| 52 Week Low | $2.32 | $1.41 |
| 52 Week High | $6.70 | $2.84 |
| Indicator | BTMD | LFT |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 46.62 |
| Support Level | $2.32 | $1.41 |
| Resistance Level | $2.90 | $1.65 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 26.83 | 38.83 |
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.
Lument Finance Trust Inc operates as a real estate investment trust. The company is engaged in investment, financing, and management of a portfolio of commercial real estate debt investments. It invests in transitional floating-rate commercial real estate mortgage loans, mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed-rate loans, construction loans, and other CRE debt instruments.